FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Bacitracin Ophthalmic Ointment
Status: Currently in Shortage
»Date first posted: 10/23/2019
»Therapeutic Categories: Ophthalmology

Perrigo Pharmaceuticals (Reverified 12/10/2019)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Bacitracin Ophthalmic Ointment 3.5 g (NDC 0574-4022-35) On backorder. Expected release early January 2020 Requirements related to complying with good manufacturing practices

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English